MEDNAX Inc to Post Q4 2019 Earnings of $0.85 Per Share, Jefferies Financial Group Forecasts (NYSE:MD) – Riverton Roll

MEDNAX Inc (NYSE:MD) Equities researchers at Jefferies Financial Group cut their Q4 2019 earnings per share (EPS) estimates for shares of MEDNAX in a report issued on Wednesday, January 22nd, Zacks Investment Research reports. Jefferies Financial Group analyst J. Plagman now expects that the company will earn $0.85 per share for the quarter, down from their prior forecast of $0.87. Jefferies Financial Group also issued estimates for MEDNAXs Q1 2020 earnings at $0.57 EPS, Q2 2020 earnings at $0.82 EPS, Q3 2020 earnings at $0.85 EPS and Q4 2020 earnings at $0.86 EPS.

MEDNAX (NYSE:MD) last announced its earnings results on Friday, November 1st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.83 by $0.08. The firm had revenue of $888.70 million during the quarter, compared to the consensus estimate of $876.20 million. MEDNAX had a negative net margin of 40.86% and a positive return on equity of 10.38%. The firms revenue for the quarter was down .9% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.94 EPS.

Several other analysts have also recently commented on the company. ValuEngine upgraded MEDNAX from a sell rating to a hold rating in a report on Friday, January 3rd. TheStreet cut MEDNAX from a c- rating to a d rating in a report on Friday, November 1st. Mizuho set a $25.00 price target on MEDNAX and gave the company a hold rating in a report on Friday, November 1st. JPMorgan Chase & Co. lifted their price target on MEDNAX from $26.00 to $33.00 and gave the company a neutral rating in a report on Friday, December 20th. Finally, Citigroup cut MEDNAX from a buy rating to a neutral rating and set a $29.00 price target for the company. in a report on Friday, January 3rd. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company. The stock currently has an average rating of Hold and a consensus price target of $27.33.

MD opened at $23.07 on Friday. The company has a debt-to-equity ratio of 1.35, a current ratio of 1.93 and a quick ratio of 1.93. The stock has a market capitalization of $1.94 billion, a price-to-earnings ratio of -1.32, a price-to-earnings-growth ratio of 0.95 and a beta of 0.78. The business has a 50-day moving average of $27.12 and a two-hundred day moving average of $24.35. MEDNAX has a 12 month low of $19.93 and a 12 month high of $38.88.

Several large investors have recently modified their holdings of MD. Millennium Management LLC lifted its position in MEDNAX by 381.5% during the 3rd quarter. Millennium Management LLC now owns 340,081 shares of the companys stock worth $7,692,000 after acquiring an additional 269,457 shares in the last quarter. Man Group plc lifted its position in MEDNAX by 97.9% during the 3rd quarter. Man Group plc now owns 431,790 shares of the companys stock worth $9,767,000 after acquiring an additional 213,629 shares in the last quarter. Assenagon Asset Management S.A. acquired a new position in MEDNAX during the 3rd quarter worth approximately $4,566,000. Nuveen Asset Management LLC acquired a new position in MEDNAX during the 2nd quarter worth approximately $4,874,000. Finally, Parametric Portfolio Associates LLC lifted its position in MEDNAX by 65.2% during the 3rd quarter. Parametric Portfolio Associates LLC now owns 475,690 shares of the companys stock worth $10,760,000 after acquiring an additional 187,750 shares in the last quarter. Institutional investors and hedge funds own 91.14% of the companys stock.

About MEDNAX

MEDNAX, Inc, together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology and teleradiology, pediatric cardiology, and other pediatric subspecialty physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care services; and acute and chronic pain management services.

MEDNAX Inc to Post Q4 2019 Earnings of $0.85 Per Share, Jefferies Financial Group Forecasts (NYSE:MD) – Riverton Roll

Categories

Archives